IL1B and relapsing-remitting multiple sclerosis: In the present study we find an increased expression of pro-inflammatory (INFG, IL1B, IL7, IL12A, IL15, IL23, LTA and LTB) and immunoregulatory cytokines (IL10 and IL27) in WB from RRMS patients in remission.